Presumptive identification of Candida spp. and other clinically important yeasts: usefulness of brilliance™ candida agar

被引：8

作者：

Alfonso, Claudia ^{[2
]}

Lopez, Monica ^{[3
]}

Arechavala, Alicia ^{[1
]}

del Carmen Perrone, Maria ^{[4
]}

Guelfand, Liliana ^{[5
]}

Bianchi, Mario ^{[1
]}

机构：

[1] Hosp Muniz, Buenos Aires, DF, Argentina

[2] Hosp Santojanni, Buenos Aires, DF, Argentina

[3] Hosp Ramos Mejia, Buenos Aires, DF, Argentina

[4] Hosp Penna, Buenos Aires, DF, Argentina

[5] Hosp Fernandez, Buenos Aires, DF, Argentina

来源：

REVISTA IBEROAMERICANA DE MICOLOGIA | 2010年 / 27卷 / 02期

关键词：

Brilliance Candida Agar; Chromogenic agar; CHROMagar; Candida spp; Presumptive identification; BLOOD-STREAM INFECTIONS; CHROMOGENIC AGAR; UNITED-STATES; GERM TUBE; SURVEILLANCE;

D O I：

10.1016/j.riam.2010.01.008

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Fungal infections caused by yeasts have increased during the last decades and invasive forms represent a serious problem for human health. Candida albicans is the species most frequently isolated from clinical samples. However, other emerging yeast pathogens are increasingly responsible for mycotic infections, and some of them are resistant to some antifungal drugs. Consequently, it is necessary to have methods that can provide a rapid presumptive identification at species level. Numerous chromogenic agar media have been shown to be of value as diagnostic tools. We have compared a chromogenic medium, Brilliance Candida Agar, with CHROMagar Candida, the chromogenic medium most used in our country. A multicentre study was conducted in 16 Hospitals belonging to the Mycology Net of Buenos Aires City Government. A total of 240 yeast isolates were included in this research. The new chromogenic agar showed results very similar to those obtained with CHROMagar Candida. (C) 2009 Revista Iberoamericana de Micologia. Published by Elsevier Espana, S.L. All rights reserved.

引用

页码：90 / 93

页数：4

共 22 条

[1]

ACOSTA G, 2005, REV MED URUG, V21, P186

[2] Epidemiology and predictors of mortality in cases of Candida bloodstream infection:: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 [J].